December, 05th | 13:15 - 14:00
FREE PAPERS - HIGHLIGHTED NEW DRUGS DME
Add to calendar
0
Chairs: CHEUNG GEMMY, LUPIDI MARCO
December, 05th | 13:15 - 13:18 Immune response of Muller cells under diabetic conditions: the jak-stat signaling pathway as a potential new target MUNK MARION Add to calendar
0
December, 05th | 13:18 - 13:21 Clinical impact of OCT-A images enhanced by a newly developed ai denoising program for retinal vascular visualization. CHEUNG GEMMY Add to calendar
0
December, 05th | 13:21 - 13:24 Brolucizumab for the treatment of proliferative diabetic retinopathy: 54-week results from the condor study WOLF SEBASTIAN Add to calendar
0
December, 05th | 13:24 - 13:27 Faricimab in dme: results from the rhone-x long-term extension trial PEARCE IAN Add to calendar
0
December, 05th | 13:27 - 13:30 Global real-world clinical and anatomical outcomes with faricimab in treatment-naïve patients with neovascular age-related macular degeneration or diabetic macular edema from a multi-country prospective non-interventional study: the voyager study PARRAVANO MARIACRISTINA Add to calendar
0
December, 05th | 13:30 - 13:33 Indirect comparison of the relative effectiveness of faricimab vs aflibercept 8 mg in diabetic macular edema (DME) and neovascular age-related macular degeneration (NAMD) LUPIDI MARCO Add to calendar
0
December, 05th | 13:33 - 13:36 48 week results from the helios phase 1 trial evaluating intravitreal otx-tki for non-proliferative diabetic retinopathy DHOOT DILSHER Add to calendar